Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3663 results

Sort By:

Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

Study ID: NCT06953466
Start Date: 2025-06-30
End Date: 2026-04-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

8

Intervention / Treatment

QRX003, 4% Lotion

Sponsor

Quoin Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients

Study ID: NCT06922825
Start Date: 2025-06
End Date: 2032-09
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

50

Intervention / Treatment

68Ga-FAPI-46

Sponsor

Eben Rosenthal

Source: clinicaltrials.gov

Share:
Add to list

A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration

Study ID: NCT06470373
Start Date: 2025-07
End Date: 2026-09
Study Type

Interventional

Study Phase

Phase3

No. of Participants

434

Intervention / Treatment

RBS-001 Solution for intravitreal injection

Eylea® Solution for intravitreal injection

Sponsor

Rophibio, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer

Study ID: NCT04243473
Start Date: 2025-06
End Date: 2033-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment
Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

Study ID: NCT06929273
Start Date: 2025-07-22
End Date: 2028-06-13
Study Type

Interventional

Study Phase

Phase3

No. of Participants

300

Intervention / Treatment

Karxt

Sponsor

Bristol-Myers Squibb

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of Non-invasive Vagus Nerve Stimulation for Axial Spondyloarthritis Resistant to Biotherapies

Study ID: NCT04286373
Start Date: 2025-09
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

active stimulation then placebo stimulation

placebo stimulation then active stimulation

Sponsor

Public assistance - Paris hospitals

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of Adjunctive At-Home Photodynamic Therapy (aPDT) in the Treatment of Peri-Implant Mucositis

Study ID: NCT06859866
Start Date: 2025-06
End Date: 2027-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Standard oral hygiene

The addition of home-based dual-light photodynamic therapy (Lumorinse® + Lumoral®)

Sponsor

Healthy

Source: clinicaltrials.gov

Share:
Add to list

2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients

Study ID: NCT06432166
Start Date: 2025-09-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

48

Intervention / Treatment

2-hydroxybenzylamine acetate

Placebo

Sponsor

MTI Biotech Inc

Source: clinicaltrials.gov

Share:
Add to list

Pilot Trial of Colchicine for Graft Failure in CABG

Study ID: NCT06802926
Start Date: 2025-07
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

100

Intervention / Treatment

Colchicine

Sponsor

Ruisin Hospital

Source: clinicaltrials.gov

Share:
Add to list

The Applicability of the Cumberland Ankle Instability Tool in Basketball Athletes.

Study ID: NCT06927557
Start Date: 2025-05-20
End Date: 2025-07-20
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment
Sponsor

Hacettepe University

Source: clinicaltrials.gov

Share:
Add to list